News
Today’s science lacks funding for truly deep innovation, says Ken Dill, PhD, UCSF School of Pharmacy faculty member and associate dean of research.
Full storyScience Cafe, Bring Back the Ivory Tower, Part 1 of 2
For the 26th consecutive year, the UCSF School of Pharmacy ranks first among US pharmacy schools in contract and grant funding from the National Institutes of Health (NIH), according to figures for fiscal year 2005. This outstanding track record of success reflects the high caliber of the School's science, agree both Mary Anne Koda-...
Victoria Hale, PhD, UCSF School of Pharmacy PhD alumnus in pharmaceutical chemistry, and founder and CEO of the Institute for OneWorld Health is one of 25 prestigious 2006 MacArthur Fellows, as announced September 19, 2006, by the John D. and Catherine T. MacArthur Foundation of Chicago, Illinois. Fellows are...
Ken A. Dill, PhD, UCSF School of Pharmacy faculty member, associate dean of research, and expert in protein folding has been named winner of the 2007 Distinguished Service Award by the Biophysical Society. Dill has served as president of the society from 1998 to 1999 and currently co-chairs the public affairs...
Michael Marletta, PhD, who completed his PhD in pharmaceutical chemistry at UCSF in 1977, was elected to the National Academy of Sciences on April 25, 2006 at the Academy's 143rd annual meeting in Washington, DC. While a PhD graduate student at UCSF, Marletta worked under research advisor George Kenyon, PhD....
Using standards that measure a university's openness and diversity, as well as distinction in research, Newsweek International ranked UCSF 9th among the top 100 global universities as reported in the publication's August 13, 2006 online issue. "The public we now serve is increasingly a global public, and this ranking is one measure of...
Pamela M. England, PhD, UCSF School of Pharmacy faculty member and expert in the areas of neuroscience and memory formation, will receive one of four Technological Innovations in Neuroscience Awards for 2006-2008. The award is from The McKnight Endowment Fund for Neuroscience.
England and her research group explore what...
Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images. This work is part of the emerging field of synthetic biology, which aims to create new biological parts, systems, and tools, and redesign existing biological systems for useful purposes,...